Cardiovascular Diseases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Diseases stocks.

Recent Signals

Date Stock Signal Type
2021-03-08 ABIO 180 Bearish Setup Bearish Swing Setup
2021-03-08 AMRN Fell Below 200 DMA Bearish
2021-03-08 AMRN Lower Bollinger Band Walk Weakness
2021-03-08 AMRN 180 Bearish Setup Bearish Swing Setup
2021-03-08 BLPH 180 Bearish Setup Bearish Swing Setup
2021-03-08 CAPR Fell Below 200 DMA Bearish
2021-03-08 FLGT Stochastic Buy Signal Bullish
2021-03-08 FLGT 50 DMA Resistance Bearish
2021-03-08 GILD Expansion Pivot Buy Setup Bullish Swing Setup
2021-03-08 GILD Crossed Above 20 DMA Bullish
2021-03-08 GILD Pocket Pivot Bullish Swing Setup
2021-03-08 GILD 200 DMA Resistance Bearish
2021-03-08 GILD Shooting Star Candlestick Bearish
2021-03-08 GILD Doji - Bearish? Reversal
2021-03-08 IRWD 50 DMA Resistance Bearish
2021-03-08 IRWD 200 DMA Resistance Bearish
2021-03-08 IRWD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-03-08 IRWD Pocket Pivot Bullish Swing Setup
2021-03-08 MESO 180 Bearish Setup Bearish Swing Setup
2021-03-08 MESO Lower Bollinger Band Walk Weakness
2021-03-08 NBIX 180 Bearish Setup Bearish Swing Setup
2021-03-08 NBIX Lower Bollinger Band Walk Weakness
2021-03-08 QLI Narrow Range Bar Range Contraction
2021-03-08 QLI New 52 Week Closing Low Bearish
2021-03-08 REGN MACD Bullish Signal Line Cross Bullish
2021-03-08 REGN 20 DMA Resistance Bearish
2021-03-08 VGAC NR7 Range Contraction
2021-03-08 VGAC Narrow Range Bar Range Contraction
2021-03-08 XOMA 180 Bearish Setup Bearish Swing Setup
2021-03-08 XOMA Slingshot Bearish Bearish Swing Setup

Recent News for Cardiovascular Diseases Stocks

Date Stock Title
Mar 9 MESO Mesoblast Closes US$110/A$138 Million Financing Led by US Strategic Investor Group
Mar 8 GILD Gilead's (GILD) CAR T Cell Therapy Yescarta Gets FDA Nod for FL
Mar 8 REGN Why herd immunity is expected later than some may believe
Mar 8 GILD Gilead announces new four year late-stage data for Biktarvy in HIV
Mar 8 FLGT FULGENT GENETIC (FLGT) Moves 8% Higher: Will This Strength Last?
Mar 8 GILD Gilead's Kite Pharma Earns FDA Nod For Yescarta For Type Of Blood Cancer
Mar 8 REGN An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 30% Undervalued
Mar 8 GILD Gilead’s Kite Receives FDA Approval For Yescarta Immunotherapy; Street Sees 17% Upside
Mar 7 REGN Regeneron (REGN) Down 7.5% Since Last Earnings Report: Can It Rebound?
Mar 7 FLGT Can Fulgent Genetics Stock Rebound?
Mar 7 GILD Gilead wins FDA approval for Yescarta in follicular lymphoma
Mar 6 IRWD The Past Week's Most Notable Insider Buys: Editas, Exxon Mobil, Wayfare And More
Mar 6 GILD Why Is Gilead (GILD) Down 1.8% Since Last Earnings Report?
Mar 6 CAPR The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Mar 6 GILD After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?
Mar 6 GILD Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI
Mar 6 GILD U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
Mar 5 GILD Money worries are holding people back from getting the vaccine
Mar 5 REGN Money worries are holding people back from getting the vaccine
Mar 5 REGN Doctor: ‘We may be reaching that critical point of herd immunity’